Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Scynexis (SCYX) Research & Development (2016 - 2025)

Historic Research & Development for Scynexis (SCYX) over the last 13 years, with Q3 2025 value amounting to $5.5 million.

  • Scynexis' Research & Development fell 3246.62% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 million, marking a year-over-year decrease of 3252.95%. This contributed to the annual value of $26.4 million for FY2024, which is 1462.43% down from last year.
  • Scynexis' Research & Development amounted to $5.5 million in Q3 2025, which was down 3246.62% from $7.1 million recorded in Q2 2025.
  • Over the past 5 years, Scynexis' Research & Development peaked at $10.6 million during Q4 2023, and registered a low of $4.3 million during Q4 2024.
  • Its 5-year average for Research & Development is $6.6 million, with a median of $6.8 million in 2023.
  • As far as peak fluctuations go, Scynexis' Research & Development surged by 5063.37% in 2022, and later tumbled by 5924.81% in 2024.
  • Scynexis' Research & Development (Quarter) stood at $7.7 million in 2021, then increased by 2.07% to $7.8 million in 2022, then skyrocketed by 34.87% to $10.6 million in 2023, then plummeted by 59.25% to $4.3 million in 2024, then grew by 26.38% to $5.5 million in 2025.
  • Its last three reported values are $5.5 million in Q3 2025, $7.1 million for Q2 2025, and $5.1 million during Q1 2025.